Inhibition of monoamine oxidase B in the brains of smokers

Nature
J S FowlerR Cilento

Abstract

The massive health problem associated with cigarette smoking is exacerbated by the addictive properties of tobacco smoke and the limited success of current approaches to cessation of smoking. Yet little is known about the neuropharmacological actions of cigarette smoke that contribute to smoking behaviour, or why smoking is so prevalent in psychiatric disorders and is associated with a decreased risk of Parkinson's disease. Here we report that brains of living smokers show a 40% decrease in the level of monoamine oxidase B (MAO B; EC 1.4.3.4) relative to non-smokers or former smokers. MAO B is involved in the breakdown of dopamine, a neurotransmitter implicated in reinforcing and motivating behaviours as well as movement. MAO B inhibition is therefore associated with enhanced activity of dopamine, as well as with decreased production of hydrogen peroxide, a source of reactive oxygen species. We propose that reduction of MAO B activity may synergize with nicotine to produce the diverse behavioural and epidemiological effects of smoking.

References

Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·G Di Chiara, A Imperato
Jan 1, 1987·Psychopharmacology·P N TariotR M Cohen
Feb 1, 1986·Journal of the Neurological Sciences·V W Yong, T L Perry
Aug 1, 1986·The American Journal of Psychiatry·J R HughesL A Dahlgren
Mar 1, 1987·Psychiatry Research·T R NormanM A French
Mar 1, 1983·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·C S PatlakJ D Fenstermacher
Dec 14, 1981·Life Sciences·L OrelandD Schalling
Jan 1, 1994·Pharmacology & Therapeutics·D M Jackson, A Westlind-Danielsson
Feb 1, 1994·Progress in Neurobiology·M D BerryI A Paterson

❮ Previous
Next ❯

Citations

Aug 6, 1999·Journal of Clinical Pharmacology·J S FowlerR Hitzemann
Jan 14, 2010·Psychopharmacology·Anne-Sophie VillégierFrances M Leslie
Mar 23, 2013·Psychopharmacology·Katharine A BrennanPenelope Truman
Dec 31, 2010·Journal of Neural Transmission·Sarah E Dixon Clarke, Rona R Ramsay
Nov 3, 2005·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Joanna S FowlerGene-Jack Wang
May 8, 2013·Brain Imaging and Behavior·Daniel S AlbrechtKarmen K Yoder
Nov 14, 2007·Clinical Reviews in Allergy & Immunology·Andrea T BorchersM Eric Gershwin
Jun 16, 2005·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Li WanNash Boutros
Oct 1, 2010·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Phillip M Rappold, Kim Tieu
Jan 16, 2004·Trends in Pharmacological Sciences·Tony P George, Stephanie S O'Malley
May 4, 2004·Trends in Pharmacological Sciences·Wassilios MeissnerErwan Bezard
Oct 10, 2002·Biological Psychiatry·Jose Maria MejiaRoberta M Palmour
Mar 30, 1999·Brain Research·O U ScreminJ C Shih
Jan 3, 2001·European Journal of Pharmacology·T ArinamiE S Onaivi
May 15, 2002·European Journal of Pharmacology·Hans RommelspacherCharlotte Kloft
Apr 20, 2000·European Journal of Pharmacology·E F Domino
Aug 7, 1998·Journal of Psychiatric Research·C K FarrenT G Dinan
Jan 1, 1997·Life Sciences·G J WangN R Pappas
Jul 23, 1998·Life Sciences·J S FowlerS J Gatley
May 17, 2000·Pharmaceutica acta Helvetiae·P A Newhouse, M Kelton
Oct 23, 1998·JPMA. the Journal of the Pakistan Medical Association·N A Jafarey
Jun 6, 2000·Pharmacology, Biochemistry, and Behavior·D J Balfour, D L Ridley
Nov 1, 2003·Pharmacology, Biochemistry, and Behavior·Anne-Sophie VillégierJean-Pol Tassin
Nov 14, 2002·Neurotoxicology·Maryka Quik, Jennifer M Kulak
Nov 14, 2002·Neurotoxicology·Donato A Di MonteAmy B Manning-Bog
Feb 5, 2003·Neurotoxicology·Joanna S FowlerNora D Volkow
Mar 7, 2002·Trends in Pharmacological Sciences·Bruno Buisson, Daniel Bertrand
Jul 6, 2000·Archives of Medical Research·S Mihailescu, R Drucker-Colín
Mar 1, 1997·Neurobiology of Aging·I IrwinJ W Langston
Jul 1, 1997·Neurobiology of Aging·J S FowlerR MacGregor
Oct 20, 2001·Progress in Neuro-psychopharmacology & Biological Psychiatry·M HarroJ Harro
Jun 24, 1998·Clinical Neurology and Neurosurgery·B A VeldmanM W Horstink

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved